Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-015905
Filing Date
2021-04-15
Accepted
2021-04-15 07:57:48
Documents
2
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2930
2 EX-24 DOCUMENT attachment1.htm EX-24 4013
  Complete submission text file 0000899243-21-015905.txt   8568
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Cogent Biosciences, Inc. (Issuer) CIK: 0001622229 (see all company filings)

EIN.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O COGENT BIOSCIENCES, INC. 200 CAMBRIDGE PARK DRIVE, SUITE 2500 CAMBRIDGE MA 02140
Business Address
Robinson John Edward (Reporting) CIK: 0001856514 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38443 | Film No.: 21827323